PL2061513T3 - Sposób leczenia pacjentów chorych na wirusowe zapalenie wątroby typu C - Google Patents

Sposób leczenia pacjentów chorych na wirusowe zapalenie wątroby typu C

Info

Publication number: PL2061513T3
Authority: PL; Poland
Prior art keywords: patients; treating hepatitis; hepatitis; relapsed; infection
Prior art date: 2007-09-14

Application number

PL08831728T

Other languages

English (en)

Inventor

Janice K Albrecht

Clifford A Brass

Robert Orville Ii Ralston

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-14

Filing date

2008-09-11

Publication date

2011-12-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40262964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2061513(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-09-11 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2011-12-30 Publication of PL2061513T3 publication Critical patent/PL2061513T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Zoology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)

PL08831728T 2007-09-14 2008-09-11 Sposób leczenia pacjentów chorych na wirusowe zapalenie wątroby typu C PL2061513T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US99375307P	2007-09-14	2007-09-14
US99876207P	2007-10-12	2007-10-12
US149407P	2007-10-30	2007-10-30
PCT/US2008/010626 WO2009038663A1 (en)	2007-09-14	2008-09-11	Method of treating hepatitis c patients
EP08831728A EP2061513B1 (en)	2007-09-14	2008-09-11	Method of treating hepatitis c patients

Publications (1)

Publication Number	Publication Date
PL2061513T3 true PL2061513T3 (pl)	2011-12-30

Family

ID=40262964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08831728T PL2061513T3 (pl)	2007-09-14	2008-09-11	Sposób leczenia pacjentów chorych na wirusowe zapalenie wątroby typu C

Country Status (17)

Country	Link
US (1)	US20100226885A1 (pl)
EP (2)	EP2061513B1 (pl)
JP (1)	JP2010539165A (pl)
CN (1)	CN101883590A (pl)
AT (1)	ATE519503T1 (pl)
AU (1)	AU2008301981A1 (pl)
CA (1)	CA2699280A1 (pl)
CY (1)	CY1112116T1 (pl)
DK (1)	DK2061513T3 (pl)
ES (1)	ES2369321T3 (pl)
HR (1)	HRP20110637T1 (pl)
MX (1)	MX2010002909A (pl)
NZ (1)	NZ583825A (pl)
PL (1)	PL2061513T3 (pl)
PT (1)	PT2061513E (pl)
SI (1)	SI2061513T1 (pl)
WO (1)	WO2009038663A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT3042910T (pt)	2010-11-30	2019-04-16	Gilead Pharmasset Llc	2'-espiro-nucleósidos para utilização na terapia da hepatite c
KR20140022855A (ko) *	2011-05-04	2014-02-25	머크 샤프 앤드 돔 코포레이션	C형 간염 바이러스의 억제제의 제조 방법
CA2840242C (en)	2011-09-16	2019-03-26	Gilead Sciences, Inc.	Methods for treating hcv
US8492386B2 (en)	2011-10-21	2013-07-23	Abbvie Inc.	Methods for treating HCV
GB2515942A (en)	2011-10-21	2015-01-07	Abbvie Inc	Combination treatment (e.g. with ABT-072 or ABT-333) of DAAs for use in treating HCV
PT107894A (pt)	2011-10-21	2014-10-31	Abbvie Inc	Métodos para o tratamento de hcv compreendendo pelo menos dois agentes antivirais de actuação directa, ribavirina, mas não interferão.
US8466159B2 (en)	2011-10-21	2013-06-18	Abbvie Inc.	Methods for treating HCV
CN104244947A (zh)	2011-10-31	2014-12-24	吉利德法莫赛特有限责任公司	用于治疗hcv的方法和组合物
AU2012346217B2 (en) *	2011-11-29	2016-02-04	Gilead Sciences, Inc.	Compositions and methods for treating hepatitis C virus
US8889159B2 (en)	2011-11-29	2014-11-18	Gilead Pharmasset Llc	Compositions and methods for treating hepatitis C virus
CA2863645A1 (en)	2012-02-01	2013-08-08	Samuel Waksal	Once daily treatment of hepatitis c with ribavirin and taribavirin
KR20200060782A (ko)	2013-01-31	2020-06-01	길리애드 파마셋 엘엘씨	두 항바이러스 화합물의 병용 제형물
US11192914B2 (en)	2016-04-28	2021-12-07	Emory University	Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6824768B2 (en) *	1998-12-18	2004-11-30	Schering Corporation	Ribavirin-pegylated interferon alfa induction HCV combination therapy
EP1140143A2 (en) *	1998-12-18	2001-10-10	Schering Corporation	Ribavirin-pegylated interferon alfa induction hcv combination therapy
CA2299893A1 (en) *	1999-03-02	2000-09-02	Carlos O. Stalgis	Hiv therapy
CN1498224A (zh)	2000-07-21	2004-05-19	��鹫˾	用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
SV2003000617A (es)	2000-08-31	2003-01-13	Lilly Co Eli	Inhibidores de la proteasa peptidomimetica ref. x-14912m
PL1730110T3 (pl)	2004-02-27	2010-11-30	Merck Sharp & Dohme	Siarkowe związki jako inhibitory proteazy serynowej NS3 wirusa zapalenia wątroby typu C
WO2006016930A2 (en) *	2004-05-14	2006-02-16	Intermune, Inc.	Methods for treating hcv infection
WO2006130553A2 (en) *	2005-06-02	2006-12-07	Schering Corporation	Hcv protease inhibitors
US20070274951A1 (en)	2006-02-09	2007-11-29	Xiao Tong	Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
AU2009256623A1 (en) *	2008-06-10	2009-12-17	Janssen Pharmaceutica Nv	Telaprevir dosing regimen

2008
- 2008-09-11 ES ES08831728T patent/ES2369321T3/es active Active
- 2008-09-11 AT AT08831728T patent/ATE519503T1/de active
- 2008-09-11 JP JP2010524864A patent/JP2010539165A/ja active Pending
- 2008-09-11 HR HR20110637T patent/HRP20110637T1/hr unknown
- 2008-09-11 DK DK08831728.4T patent/DK2061513T3/da active
- 2008-09-11 WO PCT/US2008/010626 patent/WO2009038663A1/en not_active Ceased
- 2008-09-11 EP EP08831728A patent/EP2061513B1/en not_active Revoked
- 2008-09-11 SI SI200830406T patent/SI2061513T1/sl unknown
- 2008-09-11 CN CN200880116595XA patent/CN101883590A/zh active Pending
- 2008-09-11 PT PT08831728T patent/PT2061513E/pt unknown
- 2008-09-11 US US12/376,180 patent/US20100226885A1/en not_active Abandoned
- 2008-09-11 CA CA2699280A patent/CA2699280A1/en not_active Abandoned
- 2008-09-11 EP EP11176964A patent/EP2489369A1/en not_active Withdrawn
- 2008-09-11 AU AU2008301981A patent/AU2008301981A1/en not_active Abandoned
- 2008-09-11 MX MX2010002909A patent/MX2010002909A/es not_active Application Discontinuation
- 2008-09-11 PL PL08831728T patent/PL2061513T3/pl unknown
- 2008-09-11 NZ NZ583825A patent/NZ583825A/en not_active IP Right Cessation
2011
- 2011-11-01 CY CY20111101045T patent/CY1112116T1/el unknown

Also Published As

Publication number	Publication date
NZ583825A (en)	2012-06-29
CN101883590A (zh)	2010-11-10
MX2010002909A (es)	2010-03-30
PT2061513E (pt)	2011-10-17
AU2008301981A1 (en)	2009-03-26
CA2699280A1 (en)	2009-03-26
HRP20110637T1 (hr)	2011-10-31
JP2010539165A (ja)	2010-12-16
EP2061513A1 (en)	2009-05-27
DK2061513T3 (da)	2011-11-21
CY1112116T1 (el)	2015-11-04
HK1129315A1 (en)	2009-11-27
ATE519503T1 (de)	2011-08-15
SI2061513T1 (sl)	2011-11-30
WO2009038663A1 (en)	2009-03-26
ES2369321T3 (es)	2011-11-29
EP2061513B1 (en)	2011-08-10
EP2489369A1 (en)	2012-08-22
US20100226885A1 (en)	2010-09-09

Publication	Publication Date	Title
SI2061513T1 (sl)	2011-11-30	Postopek zdravljenja pacientov s hepatitisom c
PT2219642E (pt)	2011-10-18	Componente de silibinina para o tratamento de hepatite
IL233634A0 (en)	2014-08-31	Methods, compositions and kits for treating medical conditions
TN2010000137A1 (en)	2011-09-26	Spiropyrrolidines and their use against hcv and hiv infection
IL195256A0 (en)	2009-08-03	Compositions of r(+)and s(-)pramipexole and methods of using the same
TW200528117A (en)	2005-09-01	Methods and reagents for the treatment of proliferative diseases
IL177490A0 (en)	2006-12-10	Methods for the treatment of tinnitus induced by cochlear excitotoxicity
MY144318A (en)	2011-08-29	Methods of treating hiv infection.
SG150559A1 (en)	2009-03-30	Antineoplastic combinations of cci-779 and rituximab
MY177001A (en)	2020-09-01	Phenothiazine compounds for treating mild cognitive impairment
PL1799231T3 (pl)	2010-07-30	Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli
WO2004004653A3 (en)	2004-08-26	Methods for treating psychosis associated with interferon-alpha therapy
PL1663347T3 (pl)	2008-06-30	Urządzenie do rozdzielania elementów krwi
BRPI0417108A (pt)	2007-02-06	métodos de tratamento de rejeições de transplantes em pacientes
WO2009033183A3 (en)	2009-12-30	Compounds and methods for treatment of hcv and conditions associated with cd81 binding
GB0415181D0 (en)	2004-08-11	Compounds for use in the treatment of infection
TW200631584A (en)	2006-09-16	A medicament related to mirtazapine for the treatment of hot flush
IL187160A0 (en)	2008-02-09	Compositions and methods for treating hiv infection with cupredoxin and cytochrome c
EP1827475A4 (en)	2009-08-12	METHOD FOR TREATING HIV INFECTION
GB2441094B (en)	2010-11-03	Methods for treatment and prevention of infection
UA90477C2 (ru)	2010-05-11	Способ лечения гепатита с (варианты)
GB0509911D0 (en)	2005-06-22	Medical treatment aid for use in treating children
EP1879519A4 (en)	2012-12-05	IMPLANTABLE SLINGS FOR TREATING INCONTINENCE AND USE METHOD THEREFOR
AU311512S (en)	2006-11-23	Blood or plasma treatment apparatus
IL187889A0 (en)	2008-03-20	Compositions and methods for preventing or treating hiv infection